• Mashup Score: 6

    LOS ANGELES ― The antiplatelet agent cilostazol (Pletal, Otsuka), used to treat symptoms of intermittent claudication for patients with peripheral vascular disease, may be effective in preventing restenosis after carotid stenting, a new study suggests. For the primary endpoint, analysis showed a trend toward less in-stent restenosis after carotid stenting in treated patients,…

    Tweet Tweets with this article
    • The antiplatelet agent cilostazol may be effective in preventing restenosis after carotid stenting, a new #ISC20 study suggests. https://t.co/5wdLUzsYw1

  • Mashup Score: 3

    Switching from alteplase to tenecteplase as the routine thrombolytic in acute ischemic stroke is having multiple benefits for at least one US hospital system, researchers report.

    Tweet Tweets with this article
    • Switching from alteplase to tenecteplase for stroke is having multiple benefits for one US hospital system. https://t.co/zWxqXXASOQ #ISC20

  • Mashup Score: 0

    New data from a second EXTEND-IA TNK (tenecteplase) trial clarify the optimum dose of the bolus thrombolytic for use in ischemic stroke, for which enthusiasm is growing.

    Tweet Tweets with this article
    • A second EXTEND-IA TNK trial clarifies the optimum dose of the bolus thrombolytic for use in ischemic stroke. https://t.co/2lfZkrRF65 #ISC20